RNF181 modulates Hippo signaling and triple negative breast cancer progression

BACKGROUND: Breast cancer ranks No. 1 in women cancer incidence, while triple negative breast cancer (TNBC) is the most aggressive and the worst prognostic subtype in all breast cancer subtypes. Compared with estrogen receptor alpha positive breast cancer, which could be well controlled by endocrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui, Ding, Yinlu, Xue, Min, Xiong, Bin, Zhuang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339498/
https://www.ncbi.nlm.nih.gov/pubmed/32655323
http://dx.doi.org/10.1186/s12935-020-01397-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339498/
https://www.ncbi.nlm.nih.gov/pubmed/32655323
http://dx.doi.org/10.1186/s12935-020-01397-3

Ejemplares similares